MRI Scan and Intra-labyrinthine Schwannoma

• Conditions: Schwannoma

• Registration Number: NCT03580850
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Evaluate the interest of gadolinium for the positive and topographic diagnosis of intra-labyrinthine schwannoma, comparing T1 sequence acquired after gadolinium injection to a sequence of fast imaging type employing steady state acquisition (FIESTA-C)

Detailed Description

Not available

Study Timeline

• Status Verified: 2018-02
• Study Start: 2018-02-02
• Study First Submitted: 2018-02-26
• Study First Submitted QC: 2018-06-25
• Study First Posted: 2018-07-09
• Last Update Submitted: 2018-07-11
• Last Update Posted: 2018-07-13
• Primary Completion: 2019-02
• Study Completion: 2019-02

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Age 18-80 years
• Have intra-labyrinthine schwannoma
• Have benefited from an MRI with gadolinium injection on the MRI 3T with interpretable sequences of good quality
• Subject giving their consent for their participation
• Subjects who benefited, between 2009 and 2016, from an MRI of the external auditory canals, with gadolinous product injection and on the 3 Tesla MRI, in which a diagnosis of intra labyrinthine schwannoma was made

Exclusion Criteria

• Refusal to participate in the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Presence or absence of intra labyrinthine vestibular nerve tumor using T2 FIESTA alone	1 hour after the realization of the MRI

Trial Locations

Locations (1)

Service Imagerie 1; 🇫🇷 Strasbourg, France